Hyphens Pharma International Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
See Wah Lim
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
CEO
See Wah Lim (56 yo)
7yrs
Tenure
Mr. Lim See Wah serves as Executive Chairman, Director and CEO of Hyphens Pharma International Limited. He was appointed to the Board of Hyphens Pharma International Limited on 12 December 2017. Mr. Lim Se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | no data | no data | no data | |
| Chief Financial Officer | 1.5yrs | no data | no data | |
| Chief Operating Officer | 5.3yrs | no data | 0.19% SGD 166.4k | |
| Head of HR & Admin | less than a year | no data | no data | |
| Managing Director of Pan-Malayan Pharmaceuticals & Novem Healthcare | less than a year | no data | no data | |
| Head of Regulatory Affairs | no data | no data | no data | |
| Country Head of Indonesia | no data | no data | no data | |
| Country Head of Malaysia | no data | no data | no data | |
| Country Head of Philippines | 2.9yrs | no data | no data | |
| Country Head of Vietnam | 1.4yrs | no data | no data | |
| Company Secretary | no data | no data | no data |
1.5yrs
Average Tenure
Experienced Management: 1J5's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 7yrs | no data | no data | |
| Independent Non-Executive Director | 6.7yrs | no data | no data | |
| Independent Non-Executive Director | 5.4yrs | no data | no data | |
| Non-Executive Director | 7yrs | no data | 28.05% SGD 25.1m | |
| Lead Independent Director | 6.7yrs | no data | no data | |
| Independent Director | 4.1yrs | no data | 0.039% SGD 34.8k |
6.7yrs
Average Tenure
56yo
Average Age
Experienced Board: 1J5's board of directors are considered experienced (6.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 03:47 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hyphens Pharma International Limited is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Mak | CGS International |
| Wee Kuang Tay | CGS International |
| Jiunn Chyuan Tan | KGI Securities Co. Ltd. |